University Hospitals Plymouth launches a new cryoablation treatment for kidney cancer, becoming the first in the South West ...

Kidneys help to filter waste, balance fluids, and regulate blood pressure. But like many organs, they can face silent threats ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to ...

In recognition of National Kidney Health Month, Halton Healthcare is the first regional hospital to offer renal (kidney) cryoablation, a minimally invasive procedure that targets kidney tumours ...

Cryoablation devicemaker Adagio has opted to pause the European launch of one of its catheters, to focus efforts on obtaining U.S. approval.

Boston Scientific updates Polarx catheter guidelines due to atrio-esophageal fistula risks, highlighting safer usage practices after FDA approval.

IceCure’s ProSense Cryoablation System Evaluated for Kidney Tumors in ICESECRET Interim Results December 9, 2024—IceCure Medical Ltd. recently announced interim results from the company’s ICESECRET ...

IceCure Medical’s ProSense® Cryoablation technology shows promise in treating kidney tumors with an 88.7% recurrence-free rate in patients unable to undergo surgery, based on interim results ...

IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results ...

Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe procedure for kidney tumors < 5 cm in people ineligible for surgery ...